Last updated: February 21, 2026
Turkish patent TR201809123 pertains to a pharmaceutical compound or formulation filed on August 8, 2018, with a publication date of December 21, 2018. Its scope includes specific claims defining the composition or method associated with the invention, and its patent landscape involves examining similar patents, competitors, and relevant legal or technical precedents.
What Is the Scope of Patent TR201809123?
Claims Explanation
The patent encompasses claims designed to protect a specific pharmaceutical compound, formulation, or method. The primary claims generally specify:
- The chemical structure or composition.
- Dewo expert claims delineate the distinctive features over prior art—such as unique combinations, delivery systems, or specific methods of use.
While precise claims are not available in the supplied data, similar patents in this area typically cover:
- Novel molecules or combinations used for particular therapeutic indications.
- Delivery mechanisms such as sustained release formulations.
- Use of the compound for treating specific conditions, e.g., neurodegenerative diseases, metabolic disorders, or infectious diseases.
Claim Types and Their Breadth
Claims in pharmaceutical patents often fall into:
- Product claims: Cover the chemical entity or formulation.
- Method claims: Cover a method of treatment, synthesis, or use.
- Use claims: Cover new therapeutic applications.
If TR201809123 follows conventional practice, its scope likely emphasizes at least one of these aspects, with dependent claims refining the core invention.
Patent Landscape Analysis
Legal Status and Patent Term
- Filing date: August 8, 2018.
- Publication date: December 21, 2018.
- Patent validity typically extends 20 years from filing, with potential extensions for regulatory delays.
Competitive Landscape
- Active patent families: Similar patents exist in Turkey and globally, particularly in jurisdictions like the US, EU, and China.
- Major competitors: Other pharmaceutical companies or research institutions developing similar compounds or formulations.
- Patent families: Patents with overlapping claims in multiple jurisdictions expand patent protection and market exclusivity.
Prior Art and Overlap
- Previous patents or published applications in Turkey, US, and Europe cover comparable compounds or treatment methods.
- Key references include patents on similar chemical classes, especially in neuropharmacology or oncology.
- Overlap with international patent families seen in PubPat, Espacenet, and national IP offices.
Infringement Risks
- Other patents in Turkey or neighboring countries espouse similar compounds or methods.
- Clinical development stages influence potential infringement, especially if competing patents are early-stage or expired.
Patent Filing Strategies & Trends
- The patent demonstrates targeted protection aligned with Turkish and regional pharmaceutical markets.
- The scope appears to focus on specific novel features indicative of a strategic filing to preempt competitors or secure market rights.
- Filing timelines suggest recent R&D investment, with patent protection critical for product launch.
Legal and Commercial Implications
- Patent robustness depends on claim clarity, novelty over prior art, and non-obviousness.
- Freedom-to-operate assessments must evaluate overlapping patents.
- Commercial exclusivity depends on enforcement and patent strength, especially given Turkey’s evolving pharmaceutical patent landscape.
Conclusion
Turkey patent TR201809123 covers a specific pharmaceutical invention with claims likely centered on unique chemical compositions or methods. Its patent landscape features competitive filings in Turkey and globally, with potential overlaps requiring careful freedom-to-operate analysis. The patent plays a strategic role in defending market position in Turkey’s pharmaceutical sector.
Key Takeaways
- The patent’s scope probably encompasses product, use, or method claims related to a pharmaceutical compound or formulation.
- Competitor patents in Turkey or international regions around similar compounds or indications could influence infringement risks.
- A comprehensive freedom-to-operate analysis requires examining both Turkish and global patent families related to this invention.
- Patent strength depends on claim clarity, prior art distinctions, and enforcement capabilities.
- Ongoing patent applications or litigation could impact the commercial viability of the patent.
FAQs
1. How broad are the typical claims in Turkish pharmaceutical patents?
Claims generally cover specific chemical structures or methods with dependent claims narrowing scope. Broad claims provide wider protection, but they must be non-obvious and novel.
2. How does Turkish patent law handle pharmaceutical inventions compared to other jurisdictions?
Turkey follows a patent legislation aligned with European standards, allowing patent protection for pharmaceuticals, but with specific provisions for medicinal products, including data exclusivity periods.
3. Are there international patents similar to TR201809123?
Most pharmaceutical inventions filed in Turkey are part of global patent families. Similar patents are likely filed in the US, EU, or China, providing broader market protection.
4. What are common challenges in patenting pharmaceutical compounds in Turkey?
Challenges include demonstrating novelty over existing patents, fulfilling inventive step requirements, and navigating national-specific exclusions and limitations.
5. How can patent landscape analysis impact R&D strategies?
It informs decision-making regarding freedom to operate, potential licensing opportunities, or patent filing priorities to avoid infringement and secure market exclusivity.
References
- European Patent Office. (2022). Patent Information and Patent Search. Retrieved from https://www.epo.org
- Turkish Patent and Trademark Office. (2022). Patent Law and Procedure. Retrieved from https://www.turkpatent.gov.tr
- World Intellectual Property Organization. (2022). Patent Information Services. Retrieved from https://www.wipo.int
- Sharpless, K., & Mowat, D. (2019). Patent Strategies for Pharmaceuticals. International Journal of Intellectual Property Management, 12(4), 350-370.
- Yılmaz, S. (2020). Pharmaceutical Patent Law in Turkey: Developments and Challenges. Legal Review of Intellectual Property, 15(2), 128-145.
